Here are the components to the Substance Use Disorder Evaluation that is required under He-A 507.03.
A substance use disorder evaluation shall include the administration and review of:
- The Addiction Severity Index (5th edition, 1998), to include completion of all fields within the ASI assessment (see Appendix A).
- The Driver Risk Inventory-II (DRI-II) (2007 edition), except that clients who have already taken the DRI-II as part of a screening described in He-A 507.02 shall not be required to take the test again.
- The RIASI (4th edition, 2005), except that clients who have already taken the RIASI as part of a screening described in He-A 507.02 shall not be required to take the test again.
- Any other diagnostic instrument the IDCMP deems appropriate.
If there is a positive finding, the IDCMP shall, either at the time of the evaluation or at a scheduled follow-up meeting conducted within 14 calendar days following completion of the evaluation:
- Develop an individualized service plan as described in He-A 507.04.
- Meet with the client to discuss:.
- The results of the diagnostic instruments above and the interpretation of the client’s scores;
- The evaluator’s assessment of the client’s involvement with alcohol and/or other drugs.
- The service plan requirements.
- The right to request a hearing with the DMV to rebut the service plan requirements, in accordance with RSA 265-A:40, VI, and Saf-C 204.20 (see Request for Review Hearing in Forms).
- Referral to approved treatment and recovery support providers, including, pursuant to RSA 265-A:40, VII, the client’s option to receive services from the same IDCMP that conducted the evaluation and the requirements thereof.
- Provide the client written copies of the information in (2) above.
- Obtain the client’s written acknowledgment that written copies of the information in (2) above have been provided.
- Obtain the client’s dated signature on the service plan, or an indication of the client’s refusal to sign and agree to the service plan.